In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Valeant pays €350mm cash for PharmaSwiss

Executive Summary

Strengthening its position in the Central and Eastern European branded generics market, Valeant Pharmaceuticals International Inc. (neurology and dermatology therapies) has agreed to pay €350mm ($480mm) in cash to acquire privately held PharmaSwiss SA (generics and OTC products). The deal also includes the possibility of up to €30mm in sales-based earn-outs.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Earnout
    • Payment Includes Cash

Related Companies